卡格列净与糖尿病肾病的肾脏结局 - Suppr

Suppr

超能文献

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

作者信息

Isreb Majd, Al-Makki Akram, Buatois Emily

机构信息

Washington State University Elson S. Floyd College of Medicine, Vancouver, WA

Indiana University Health Arnett Hospital, Lafayette, IN.

出版信息

N Engl J Med. 2019 Sep 12;381(11):1088. doi: 10.1056/NEJMc1909687.

DOI:10.1056/NEJMc1909687

PMID:31509682

Abstract

摘要

相似文献

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1088. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1087-1088. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1088-1089. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1089. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply.

N Engl J Med. 2019 Sep 12;381(11):1089-1090. doi: 10.1056/NEJMc1909687.

SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?

J Am Soc Nephrol. 2017 Jan;28(1):7-10. doi: 10.1681/ASN.2016060650. Epub 2016 Aug 18.

Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.

Am J Nephrol. 2017;46(6):459-461. doi: 10.1159/000484669. Epub 2017 Dec 11.

Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease.

Nat Rev Nephrol. 2018 Feb;14(2):78-80. doi: 10.1038/nrneph.2017.182. Epub 2018 Jan 8.

A Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease.

Kidney360. 2022 May 18;3(9):1599-1602. doi: 10.34067/KID.0002172022. eCollection 2022 Sep 29.

Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease.

J Diabetes Complications. 2018 Jul;32(7):720-725. doi: 10.1016/j.jdiacomp.2018.04.011. Epub 2018 May 5.

引用本文的文献

Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Front Endocrinol (Lausanne). 2021 Jan 15;11:604250. doi: 10.3389/fendo.2020.604250. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1088. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1087-1088. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1088-1089. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

N Engl J Med. 2019 Sep 12;381(11):1089. doi: 10.1056/NEJMc1909687.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply.

N Engl J Med. 2019 Sep 12;381(11):1089-1090. doi: 10.1056/NEJMc1909687.

SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?

J Am Soc Nephrol. 2017 Jan;28(1):7-10. doi: 10.1681/ASN.2016060650. Epub 2016 Aug 18.

Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.

Am J Nephrol. 2017;46(6):459-461. doi: 10.1159/000484669. Epub 2017 Dec 11.

Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease.

Nat Rev Nephrol. 2018 Feb;14(2):78-80. doi: 10.1038/nrneph.2017.182. Epub 2018 Jan 8.

A Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease.

Kidney360. 2022 May 18;3(9):1599-1602. doi: 10.34067/KID.0002172022. eCollection 2022 Sep 29.

Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease.

J Diabetes Complications. 2018 Jul;32(7):720-725. doi: 10.1016/j.jdiacomp.2018.04.011. Epub 2018 May 5.

引用本文的文献

Front Endocrinol (Lausanne). 2021 Jan 15;11:604250. doi: 10.3389/fendo.2020.604250. eCollection 2020.

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

作者信息

Isreb Majd, Al-Makki Akram, Buatois Emily

机构信息

Washington State University Elson S. Floyd College of Medicine, Vancouver, WA

Indiana University Health Arnett Hospital, Lafayette, IN.

出版信息

N Engl J Med. 2019 Sep 12;381(11):1088. doi: 10.1056/NEJMc1909687.

DOI:10.1056/NEJMc1909687

PMID:31509682

Abstract

摘要